Scleroderma :

Transcription

Scleroderma :
National Scleroderma Conference
Scleroderma :
Hard Word. Harder Disease. Great Conference.
“As hard as it is, it can be easier,”
says Michelle Richard, president of the
Scleroderma Society of Canada. “Making it
easier starts by becoming personally engaged,
educated and empowered. A great place to do
that is the National Scleroderma Conference.”
S C LE R O D E R M A
It’s hard to pronounce and harder
to live with.
This progressive,
connective-tissue disease can scar
internal organs, harden skin, cause stiff
joints, damage lungs and cause kidney
failure. At its worst, scleroderma leads
to severe disability and disfiguring, and
even death. It has no known cause
and no cure.
Scleroderma is a hard disease. It’s hard
for researchers to understand and for
healthcare professionals to treat. It’s
hard on caregivers and families. It’s
especially hard on the people living
with the disease.
Michelle Richard,
President
Scleroderma Canada
The 2016 Bilingual National Scleroderma Conference offers the chance to
engage the way you want to, the way that helps you most and in ways that allow
you to contribute to the scleroderma community. You can absorb the newest
information, learn from the experience of others, and gain insight from researchers,
physicians and professional caregivers. This is a great opportunity to be part of
Canada’s supportive scleroderma community.
The 17th annual Bilingual Scleroderma Conference takes place on
September 16 and 17, 2016 at the Hotel Bonaventure Montréal.
Everyone is welcome – healthcare professionals, researchers, advocates,
volunteers, care providers, friends and family and, of course, people
living with scleroderma.
Several keynote speakers have already confirmed their attendance.
Workshops covering various topics such as lung disease, Raynaud’s phenomenon and digital ulcers,
the medication component, dental care and Scleroderma,
will provide an opportunity for participants to exchange with experts.
Dr. Jean-Luc Senécal
Dr. Mervyn Gornitsky
Holder of the Scleroderma
Research Chair
University of Montreal
Research Director,
Department of Dentistry
McGill University
Dr. Arthur Bookman, Dr. Marie Hudson, Dr. Alena Ikic,
Dr. Dinesh Khanna, Dr. Maureen Mayes, Dr. Janet Pope, Dr. Steeve Provencher,
Dr. Ronald Laxer, Dr. Ariel Masetto, Dr. Éric Rich and Mrs. Marie-Eve Prince.
National Scleroderma Conference
17th Annual National
SCLERODERMA
Conference
September
2
0
1
6
16 - 17
Hotel Bonaventure Montréal
For the National Scleroderma
Conference related inquiries
or registration:
Please contact Scleroderma Quebec
Toll free: 1 844 990-6789
Email:
[email protected]
Online at :
www.sclerodermafoundation.ca
Registration fees include admission to
all conference sessions, refreshments
breaks, Saturday continental breakfast
and lunch.
Conference Registration Rates
Early Bird: $75.00 (Adult Rate until July 15,
2016. This ticket type will change to $95.00
after July 15)
Accommodations
A limited number guest rooms are on hold
for conference participants at a preferred
rate of $179/night plus tax per night for a
single or double room. To book please call
514-878-2332 or Toll Free 1-800-267-2575 and
mention “Scleroderma Conference 2016”.
Once the block of rooms is booked, rates and
reservations cannot be guaranteed.
Hotel Bonaventure Montréal
900 Rue de la Gauchetière W
Montreal, QC H5A 1E4
Tel: 514.878.2332
Toll free: 1.800.267.2575
www.hotelbonaventure.com
A full description
of the program
is available
at www.
sclerodermafoundatio
n.ca

Similar documents

An invitation to the

An invitation to the at the Bonaventure Hotel located in downtown Montreal. Scleroderma Quebec is pleased to present, in collaboration with the Scleroderma Society of Canada, this great gathering of patients, families ...

More information

Systemic Sclerosis (Scleroderma) Market Statistics, Causes,Treatment, Pipeline Review, H1 2016

Systemic Sclerosis (Scleroderma) Market Statistics, Causes,Treatment, Pipeline Review, H1 2016 Global Markets Direct's, 'Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016', provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape. Read More @ http://www.radiantinsights.com/research/systemic-sclerosis-scleroderma-pipeline-review-h1-2016

More information